 |
|
|
|
 |
|
|
 Contact |  Print version |  PDF version |  Recommend company
|
Technologiepark 4
9052 Ghent/Zwijnaarde
Belgium
|
|
Portrait
Ablynx, a biopharmaceutical company with headquarters in Ghent, Belgium, is engaged in the discovery and development of Nanobodies® to treat a range of serious human diseases. Nanobodies® are a novel class of antibody-derived therapeutic proteins. Because of their small size, unique structure and extreme stability, Nanobodies® combine the advantages of conventional antibody therapeutics with the key features of small-molecule drugs.
Industrial Sectors
Additional information
Ablynx nv
Ghent/Zwijnaarde, Belgium
News
|
|
|
|
|
|
Top
